SCHEMBL7659797

SCHEMBL7659797

Cc1cc(Nc2ccccc2)ccn1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.53
ALDH1A1 P00352 3/20 0.52
MAPT P10636 3/20 0.52
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
AR P10275 1/20 0.52
KDR P35968 1/20 0.49
TGFBR1 P36897 1/20 0.49
HPGD P15428 2/20 0.48
HSD17B10 Q99714 3/20 0.48
ACVRL1 P37023 1/20 0.47
HDAC3 O15379 1/20 0.46
HDAC1 Q13547 1/20 0.46
HDAC2 Q92769 1/20 0.46
HDAC6 Q9UBN7 1/20 0.46
TSHR P16473 2/20 0.46
TDP1 Q9NUW8 2/20 0.46
MAPK1 P28482 2/20 0.46
ALOX15 P16050 1/20 0.46
ALOX12 P18054 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31494286 1.00 NPSR1 (0.53) NPSR1ALDH1A1MAPTMEN1KMT2A
SCHEMBL25820900 0.84 SMARCA2 (0.61) MAPTMEN1KMT2AKDRHSD17B10
SCHEMBL24004058 0.82 KDM4E (0.56) ALDH1A1MAPTMEN1KMT2AKDR
SCHEMBL30180617 0.81 RAD52 (0.57) ALDH1A1MAPTMEN1KMT2AKDR
SCHEMBL23999529 0.81 RAD52 (0.57) ALDH1A1MAPTMEN1KMT2AKDR
SCHEMBL24010655 0.80 NPC1 (0.58) HDAC3HDAC1HDAC2HDAC6L3MBTL1
SCHEMBL24003834 0.80 KCNK3 (0.55) MEN1KMT2A
SCHEMBL30232524 0.80 KCNK3 (0.55) MEN1KMT2A
SCHEMBL24010657 0.80 BRAF (0.57) ALDH1A1MAPTMEN1KMT2A
SCHEMBL30290919 0.80 BRAF (0.57) ALDH1A1MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200352917-A1 MEDICATED SPRAY FOR TREATMENT OF SUBSTANCE ABUSE, OVERDOSE, ADDICTION AND IMPULSE CONTROL DISORDERS GOOBERMAN LANCE L (US) 2020-11-12 US disclosed
WO-2015066697-A1 FUSED MORPHOLINOPYRIMIDINES AND METHODS OF USE THEREOF FORUM PHARMACEUTICALS INC. (US) 2015-05-07 WO disclosed
US-6362009-B1 CAPTURING A SUBSTRATE ON SOLID SUPPORT AND ACTIVATINGSUBSTRATE TO REACT WITH REAGENT WITH WHICH UNACTIVATED SUBSTRATE DOES NOT REACT; REACTING ACTIVATED SUBSTRATE ON SOLID PHASE WITH REAGENT TO GIVE AN ADDITION PRODUCT MERCK & CO., INC. 2002-03-26 US disclosed